Lastly, this study aims to identify prognostic markers and potential therapeutic targets for ccRCC using bioinformatics approaches, and the exploration of the specific biological mechanisms of the five activated DC genes is limited. This evidence concerns the gene DCX and nonpapillary renal cell carcinoma.